Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis

Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis

Murine models of coxsackievirus B3 (CVB3)-induced myocarditis well represent the different outcomes of this inflammatory heart disease. Previously, we found that CVB3-infected A.BY/SnJ mice, susceptible for severe acute and chronic myocarditis, have lower natural killer (NK) cell levels than C57BL/6...

Full description

Bibliographic Details
Main Authors:	Irene Müller, Lisa Janson, Martina Sauter, Kathleen Pappritz, Sophie Van Linthout, Carsten Tschöpe, Karin Klingel
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Viruses
Subjects:	myeloid-derived suppressor cells myocarditis coxsackievirus B3 natural killer cells
Online Access:	https://www.mdpi.com/1999-4915/13/5/889

Similar Items

Opioid-Induced Immunomodulation: Consequences for the Experimental Coxsackievirus B3-Induced Myocarditis Model
by: Kathleen Pappritz, et al.
Published: (2020-10-01)

In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell<sup>®</sup> Cardiomyocytes
by: Lisa Kraft, et al.
Published: (2021-09-01)

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
by: Cristina Zalfa, et al.
Published: (2021-05-01)

Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
by: Kathleen Pappritz, et al.
Published: (2022-04-01)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01)

Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis
by: Ha-Hyeon Shin, et al.
Published: (2023-03-01)

Melatonin Ameliorates Coxsackievirus B3-Induced Myocarditis by Regulating Apoptosis and Autophagy
by: Yimiao Sang, et al.
Published: (2018-12-01)

Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
by: Nicola Tumino, et al.
Published: (2022-01-01)

CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
by: Wei Heng, et al.
Published: (2020-12-01)

Treatment Trends of Myocarditis with Coxsackievirus B3 infection
by: Dalya Basil Hanna, et al.
Published: (2020-06-01)

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis
by: Carsten Tschöpe, et al.
Published: (2020-10-01)

Coxsackievirus B3 directly induced Th17 cell differentiation by inhibiting Nup98 expression in patients with acute viral myocarditis
by: Qi Long, et al.
Published: (2016-12-01)

Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes
by: Soo-Hyeon Yun, et al.
Published: (2020-04-01)

Oral administration of interferon-α2b-transformed <it>Bifidobacterium longum </it>protects BALB/c mice against coxsackievirus B3-induced myocarditis
by: Yu Zhijian, et al.
Published: (2011-12-01)

IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis
by: Miao Yu, et al.
Published: (2016-10-01)

The Evolution of Pleconaril: Modified <i>O</i>-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
by: Alexandrina Volobueva, et al.
Published: (2020-03-01)

GMI, an Immunomodulatory Peptide from <i>Ganoderma microsporum</i>, Restrains Periprosthetic Joint Infections via Modulating the Functions of Myeloid-Derived Suppressor Cells and Effector T Cells
by: Kuo-Ti Peng, et al.
Published: (2021-06-01)

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
by: Jens Kurreck, et al.
Published: (2011-10-01)

Short hairpin RNA targeting 2B gene of coxsackievirus B3 exhibits potential antiviral effects both <it>in vitro</it> and <it>in vivo</it>
by: Yao Hailan, et al.
Published: (2012-08-01)

Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)

Vaccines against Group B Coxsackieviruses and Their Importance
by: Kiruthiga Mone, et al.
Published: (2023-01-01)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
by: Zhaonian Hao, et al.
Published: (2021-10-01)

Development of antiviral therapeutics combating coxsackievirus type B3 infection
by: A. S. Volobueva, et al.
Published: (2021-02-01)

PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis
by: Mahima T. Rasquinha, et al.
Published: (2022-07-01)

Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells
by: Kyu Hwan Kwack, et al.
Published: (2022-10-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice
by: Dan Xu, et al.
Published: (2018-05-01)

Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model
by: Sandra Pinkert, et al.
Published: (2021-06-01)

Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity
by: Lee-Hwa Tai, et al.
Published: (2018-06-01)

The Four-Way Stop Sign: Viruses, 12-Lipoxygenase, Islets, and Natural Killer Cells in Type 1 Diabetes Progression
by: Michele L. Semeraro, et al.
Published: (2017-09-01)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)

Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
by: Weitao Zhang, et al.
Published: (2018-01-01)

Miocarditis fulminante y enfermedad diarreica aguda por Coxsackie virus B6 Fulminant myocarditis and acute gastroenteritis due to Coxsackie virus B6
by: Germán Málaga, et al.
Published: (2011-03-01)

Immunoregulatory functions of innate lymphoid cells
by: Sarah Q. Crome, et al.
Published: (2018-11-01)

Myeloid-derived suppressor cells inhibit natural killer cells in myelodysplastic syndromes through the TIGIT/CD155 pathway
by: Jing Yue, et al.
Published: (2023-12-01)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
by: Shunjie Yu, et al.
Published: (2022-07-01)

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
by: María Luisa Sánchez-León, et al.
Published: (2022-11-01)

Myocarditis in Humans and in Experimental Animal Models
by: Przemysław Błyszczuk, et al.
Published: (2019-05-01)